NCT06652672View on ClinicalTrials.gov

Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma

NARecruitingINTERVENTIONAL
Enrollment

325

Participants

Timeline

Start Date

December 12, 2024

Primary Completion Date

December 12, 2030

Study Completion Date

December 12, 2032

Conditions
Colon CancerColon AdenocarcinomaSentinel Lymph NodeSentinel Lymph Node BiopsyColon NeoplasmsColon NeoplasmFluorescenceFluorescence Guided SurgeryFluorescence LaparoscopyFluorescence-guided ResectionColon SurgeryIndocyanine Green (ICG)
Interventions
PROCEDURE

Organ-sparing surgery

Endoscopy-assisted laparoscopic/robotic wedge resection and sentinel lymph node biopsy using submucosal injection of ICG.

PROCEDURE

Standard of care segmental resection

Standard of care segmental resection of the affected part of the colon including removal of regional lymph nodes.

Trial Locations (1)

Unknown

RECRUITING

Meander Medisch Centrum, Amersfoort

Sponsors
All Listed Sponsors
lead

Meander Medical Center

OTHER